Autoimmune diseases Trials in Boston, United States
Conditions / Autoimmune diseases / Boston, United States
Autoimmune diseases has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01351545 | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) | RECRUITING | — |
| NCT03656627 | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | TERMINATED | PHASE1 |
| NCT01758042 | Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders | COMPLETED | NA |
| NCT04015596 | Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS | TERMINATED | PHASE4 |
| NCT00035308 | Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease | COMPLETED | PHASE3 |
| NCT00039988 | Treatment of Multiple Sclerosis With Copaxone and Albuterol | COMPLETED | NA |
| NCT03490539 | Disease-Modifying Treatments for Myasthenia Gravis | COMPLETED | — |
| NCT01351805 | Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | COMPLETED | NA |
| NCT02682511 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | ACTIVE_NOT_RECRUITING | — |
| NCT01582880 | Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis | COMPLETED | PHASE1/PHASE2 |